Магнитно-резонансная томография в выявлении рецидива рака предстательной железы
- Авторы: Шария М.А1, Глыбочко П.В1, Терновой С.К1, Петровский Н.В1
-
Учреждения:
- ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет)
- Выпуск: № 4 (2018)
- Страницы: 172-178
- Раздел: Статьи
- URL: https://journals.eco-vector.com/1728-2985/article/view/296380
- DOI: https://doi.org/10.18565/urology.2018.4.172-178
- ID: 296380
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Полный текст
Об авторах
М. А Шария
ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет)
Email: mershar@yandex.ru
д.м.н., профессор, ведущий научный сотрудник отдела томографии; профессор кафедры лучевой диагностики и терапии
П. В Глыбочко
ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет)академик РАН, д.м.н., профессор, ректор
С. К Терновой
ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет)академик РАН, заведующий кафедрой лучевой диагностики и терапии; главный научный сотрудник отдела томографии
Н. В Петровский
ФГАОУ ВО «Первый МГМУ им. И. М. Сеченова» Минздрава России (Сеченовский Университет)доцент кафедры урологии
Список литературы
- Siegel R.L., Miller K.D., Jemal A. Cancer Statistics, 2017. CA Cancer J. Clin. 2017;67:7.
- Pinkawa M. External beam radiotherapy for prostate cancer. Panminerva Medica. 2010;52(3):195-207.
- Barchetti F., Panebianco V. Multiparametric MRI for recurrent prostate cancer post radical prostatectomy and postradiation therapy. BioMed Research International Volume. 2014;1-23.
- Murphy A.M., Berkman D.S., Desai M., et al. The number of negative pelvic lymph nodes removed does not affect the risk of biochemical failure after radical prostatectomy.BJUInt. 2010;105(2):176-179.
- Olsson A. Y., Bjartell A., Lilja H., et al. Expression of Prostate-specific antigen (PSA) and human glandular kallikrein 2 (hK2) in ileum and other extraprostatic tissues. International Journal of Cancer. 2005;113(2):290- 297.
- Cornford P., Bellmunt J., Bolla M., et al. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 2: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer. Eur Urol. 2017 ;71(4):630-642. doi: 10.1016/j.eururo.2016.08.002. Epub 2016 Aug 31.
- Paller C.J., Antonarakis E.S. Management of biochemically recurrent prostate cancer after local therapy: evolving standards of care and new directions. Clin Adv Hematol Oncol. 2013;11(1):14-23.
- Scattoni V., Montorsi F., Picchio M. et al. Diagnosis of local recurrence after radical prostatectomy. BJU Int. 2004;93(5):680-688.
- Коробкин А.С., Шария М.А., Устюжанин Д.В., Восканян Г.А., Винаров А.З. Диагностическое значение современных методик МРТ (МРС, ДВИ, перфузии) в выявлении рака предстательной железы. Российский электронный журнал лучевой диагностики (Приложение). 2014;3(2):155-56
- De Visschere P.J., De Meerleer G.O., Fütterer J.J., Villeirs G.M. Role of MRI in Follow-Up after focal therapy for prostate carcinoma. Am J. Roentgenol. 2010;194:1427-1433.
- Kim J.K., Jang Y.J., Cho G. Multidisciplinary functional MR Imaging for prostate cancer. Korean J. Radiol. 2009;10:535-551.
- Коробкин А.С., Шария М.А., Восканян Г.А., Винаров А.З. МР-спектроскопия в диагностике рака предстательной железы. Российский электронный журнал лучевой диагностики (Приложение). 2013;3(2):143-144
- Nguyen D.P., Giannarini G., Seiler R. et al. Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site. BJU Int. 2013;112(4):243-249.
- Panebianco V., Barchetti F., Grompone M.D., et al. Magnetic resonance imaging for localization of prostate cancer in thesetting of biochemical recurrence. UrolOncol. 2016;34(7):303-311.
- Sefrova J., Odrazka K., Paluska P. et al. Magnetic resonance imaging in postprostatectomy radiotherapy planning. Int J. RadiatOncolBiolPhys. 2012;82(2):911-918.
- Lindenberg L., Ahlman M., Turkbey B., et al. Evaluation of Prostate Cancer with PET/MRI. J. Nucl Med. 2016;57:111-116.
- Silverman J.M., Krebs T.L. MRimaging evaluationwith a transrectal surface coil of local recurrence of prostatic cancer in men who have undergone radical prostatectomy. Am J. Roentgenol. 1997 ; 168(2):379- 385.
- Panebianco V., Sciarra A., Lisi D. et al. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP). Eur J. Radiol. 2012;81(4):700- 708.
- Sciarra A., Panebianco V., Salciccia S. et al. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer. Eur Urol. 2008;54(3):589-600.
- Wu L.M., Xu J.R., Gu H. Y. et al. Role ofmagnetic resonance imaging in the detection of local prostate cancer recurrence after external beam radiotherapy and radical prostatectomy. ClinOncol (R CollRadiol). 2013;25(4):252-364.
- Giannarini G., Nguyen D.P., Thalmann G.N., Thoeny H.C. Diffusion-weighted magnetic resonance imaging detects local recurrence after radical prostatectomy: initial experience. Eur Urol. 2012;61(3):616-620.
- Kim C.K., Park B.K., Park W., Kim S.S. Prostate MR imaging at 3T using a phased-arrayed coil in predicting locally recurrent prostate cancer after radiation therapy: preliminary experience. Abdom Imaging. 2010;35(2):246-252.
- Kim C.K., Park B.K., Lee H.M. Prediction of locally recurrent prostate cancer after radiation therapy: incremental value of 3T diffusion-weighted MRI. J. MagnReson Imaging. 2009;29:391-397.
- Panebianco V., Barchetti F., Sciarra A. et al. Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging.Eur J. Radiol. 2013;23(6):1745- 1752.
- Moman M.R., van den Berg C.A., Boeken Kruger A.E. et al. Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int J. RadiatOncolBiolPhys. 2010;76(3):741-746.
- Arumainayagam N., Kumaar S., Ahmed H.U. et al. Accuracy of multiparametric magnetic resonance imaging in detecting recurrent prostate cancer after radiotherapy. BJU Int. 2010;106:991-997.
- Roy C., Foudi F., Charton J. et al. Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy. Am J. Roentgenol. 2013;200(4):361-368.
- Donati O.F., Jung S.I., Vargas H.A. et al. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: Are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Radiology. 2013;268:440-450.
- Westphalen A.C., Kurhanewicz J., Cunha R.M.G. et al.T2-weighted endorectal magnetic resonance imaging of prostate cancer after external beam radiation therapy. IntBraz J. Urol. 2009;35(2):171-182.
- Schiavina R., Ceci F., Borghesi M. et al. The dilemma of localizing disease relapse after radical treatment for prostate cancer: which is the value of the actual imaging techniques? Current Radiopharmaceuticals. 2013;6(2):92-95.
- Oppenheimer D.C., Weinberg E.P., Hollenberg G.M., Meyers S.P. Multiparametricmagnetic resonance imaging of recurrent prostate cancer. J Clin Imaging Sci. 2016;29:6-18.
- De Visschere P.J., De Meerleer G.O., Fütterer J.J., Villeirs G.M. Role of MRI in follow-up after focal therapy for prostate carcinoma. Am J Roentgenol. 2010;194(6):1427-1433.
- Kara T., Akata D., Akyol F. et al. The value of dynamic contrast-enhanced MRI in the detection of recurrent prostate cancer after external beam radiotherapy: correlation with transrectal ultrasound and pathological findings. Diagn Interv Radiol. 2011;17(1):38-43.
- Panebianco V., Barchetti F., Musio D. et a l.Metabolic atrophy and 3T 1H-MR spectroscopy correlation after radiation therapy for prostate cancer. BJU Int. 2014;114(6):852-859.
- Morgan V.A., Riches S.F., Giles S. et al. Diffusion-weighted MRI for locally recurrent prostate cancer after external beamradiotherapy. Am J Roentgenol. 2012;198(3):596-602.
- Hamstra D.A., Rehemtulla A., Ross B.D. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J ClinOncol. 2007;25(26):4104-4109.
- De Souza N.M., Reinsberg S.A., Scurr E.D. et al. Magnetic resonance imaging in prostate cancer the value of apparent diffusion coefficients for identifying malignant nodules. Br J Radiol. 2007;80(950):90-95.
- Song I., Kim C.K., Park B.K., Park W. Assessment of response to radiotherapy for prostate cancer: value of diffusion weighted MRI at 3 T.Am J Roentgenol. 2010;194(6): 477-482.
- Liu L., Wu N., Ouyang H., Dai J.R., Wang W.H. Diffusion-weighted MRI in early assessment of tumour response to radiotherapy in high-risk prostate cancer. Br J Radiol. 2014;87(1043):20140359. doi: 10.1259/bjr.20140359.
- Grant K.B., Agarwal H.K., Shih J.H. et al. Comparison of calculated and acquired high b-value diffusion weighted imaging in prostate cancer. Abdom Imaging. 2015;40(3):578-586.
- Tamada T., Sone T., Jo Y. et al. Locally recurrent prostate cancer after high-dose-rate brachytherapy: the value of diffusionweighted imaging, dynamic contrast-enhanced MRI and T2- weighted imaging in localizing tumors. Am J Roentgenol. 2011;197(2):408-414.
- Donnelly S.E., Donnelly B.J., Saliken J.C. et al. Prostate cancer: gadolinium-enhanced MR imaging at 3 weeks compared with needle biopsy at 6 months after cryoablation. Radiology 2004;232:830-833.
- Beresford M.J., Gillatt D., Benson R.J., Ajithkumar T. A systematic review of the role of imaging before salvage radiotherapy for post-prostatectomy biochemical recurrence. ClinOncol (R CollRadiol). 2010;22(1):46-55.